Literature DB >> 23224452

The effects of comorbid obsessive-compulsive disorder and attention-deficit hyperactivity disorder on quality of life in tourette syndrome.

Clare M Eddy1, Andrea E Cavanna, Mariangela Gulisano, Paola Calì, Mary M Robertson, Renata Rizzo.   

Abstract

Tourette syndrome (TS) is a complex neuropsychiatric disorder affecting patients' quality of life (QoL). The authors compared QoL measures in young patients with "pure" TS (without comorbid conditions) versus those with TS+OCD (obsessive-compulsive disorder), TS+ADHD (attention-deficit hyperactivity disorder), or TS+OCD+ADHD. Age and scores on scales assessing tic severity, depression, anxiety, and behavioral problems were included as covariates. Young patients with both comorbidities exhibited significantly lower Total and Relationship Domain QoL scores, versus patients with pure TS. Across the whole sample, high ADHD-symptom scores were related to poorer QoL within the Self and Relationship domains, whereas high OCD symptom scores were associated with more widespread difficulties across the Self, Relationship, Environment, and General domains. Significant differences in QoL may be most likely when both comorbidities are present, and features of OCD and ADHD may have different impacts on QoL across individual domains.

Entities:  

Mesh:

Year:  2012        PMID: 23224452     DOI: 10.1176/appi.neuropsych.11080181

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  15 in total

1.  Tourette syndrome and socioeconomic status.

Authors:  Mark Aldred; Andrea E Cavanna
Journal:  Neurol Sci       Date:  2015-04-21       Impact factor: 3.307

2.  Quality of life in children with OCD before and after treatment.

Authors:  Bernhard Weidle; Tord Ivarsson; Per Hove Thomsen; Stian Lydersen; Thomas Jozefiak
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-12-20       Impact factor: 4.785

3.  Living with tics: reduced impairment and improved quality of life for youth with chronic tic disorders.

Authors:  Joseph F McGuire; Elysse Arnold; Jennifer M Park; Joshua M Nadeau; Adam B Lewin; Tanya K Murphy; Eric A Storch
Journal:  Psychiatry Res       Date:  2014-12-04       Impact factor: 3.222

4.  Comprehensive systematic review summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders.

Authors:  Tamara Pringsheim; Yolanda Holler-Managan; Michael S Okun; Joseph Jankovic; John Piacentini; Andrea E Cavanna; Davide Martino; Kirsten Müller-Vahl; Douglas W Woods; Michael Robinson; Elizabeth Jarvie; Veit Roessner; Maryam Oskoui
Journal:  Neurology       Date:  2019-05-07       Impact factor: 9.910

5.  The Obsessive-Compulsive Symptoms in Tic Disorders and the Psychometric Properties of Children's Yale-Brown Obsessive-Compulsive Scale: An Evidence-Based Survey in a Chinese Sample.

Authors:  Junjuan Yan; Yi Gu; Mengyu Wang; Yonghua Cui; Ying Li
Journal:  Front Pediatr       Date:  2022-06-09       Impact factor: 3.569

Review 6.  The Semiology of Tics, Tourette's, and Their Associations.

Authors:  Christos Ganos; Alexander Münchau; Kailash P Bhatia
Journal:  Mov Disord Clin Pract       Date:  2014-06-10

7.  Quality of life in children with OCD with and without comorbidity.

Authors:  Bernhard Weidle; Thomas Jozefiak; Tord Ivarsson; Per Hove Thomsen
Journal:  Health Qual Life Outcomes       Date:  2014-10-29       Impact factor: 3.186

8.  Tourette syndrome and consciousness of action.

Authors:  Andrea E Cavanna; Andrea Nani
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2013-09-23

9.  Comorbidities, Social Impact, and Quality of Life in Tourette Syndrome.

Authors:  Valsamma Eapen; Andrea E Cavanna; Mary M Robertson
Journal:  Front Psychiatry       Date:  2016-06-06       Impact factor: 4.157

Review 10.  The effects of Gilles de la Tourette syndrome and other chronic tic disorders on quality of life across the lifespan: a systematic review.

Authors:  Joel Evans; Stefano Seri; Andrea E Cavanna
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-02-15       Impact factor: 4.785

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.